U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07268690) titled 'Risk-Adapted Omission of Level Va Irradiation in Nasopharyngeal Carcinoma' on Nov. 23.
Brief Summary: This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. This study will evaluate whether omitting Level Va irradiation in patients without these risk features does not compromise regional control or survival, with the goal of providing robust evidence to guide further personalization of NPC radiotherapy.
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Nasopharyngeal Carcinoma by AJCC V9 Stage
Intervention:
RADIA...